The Lancet Summit: shaping the future of diabetes prevention. Image credit: Ixefra / Getty Images

📣 Preliminary programme announced!

15 renowned academic and lived experience experts will lead an exceptional programme highlighting lessons learned in preventing #diabetes

View the programme and submit your abstracts by Jun 12: hubs.li/Q03MV4_x0

#T1D #T2D #ADASciSessions

Stop by #dkNET booth #1129 #CellBio2025 to learn how our new Computational Core can streamline your research! Don’t miss the chance to meet the team and explore how we can support your research. dknet.org/about/blog/2... #cloud #dkNET #ADASciSessions

American Diabetes Association Archives Presenting research from the annual meeting of the American Diabetes Association.

Looking to catch up on research from #ADASciSessions? Check out Endocrinology Advisor's coverage below ⬇️
#ADA2025 #EndoSky #MedSky @amdiabetesassn.bsky.social

“If you treat someone’s blood pressure or cholesterol you don’t get improvements in quality of life. You treat their weight you get all the benefits."

"That is the power of treating obesity.”

Inspiring talk by Dr. Lou Aronne on the clinical implications of CagriSema at #ADASciSessions #ADA2025

Check out #dkNET community news, events and #funding announcements in July 2025! dknet.org/about/blog/2...
#bioinformatics #endocrinology #diabetes #FAIRdata #webinar #datascience #T1D #ADASciSessions #ADA2025 #T2D #SummerProgram

GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025 From 2019 to 2024, GLP-1 prescriptions among pediatric patients with type 2 diabetes increased from 12.3% to 60.9%.

New data presented at the ADA 2025 Scientific Sessions reveals an increase in GLP-1 receptor agonist use among pediatric patients with type 2 #diabetes over the past five years. #ADASciSessions

Read More: bit.ly/4lpHs9l

Pharmacist-Led Diabetes Coaching Improved Glycemic Control, Reduced Expenses | ADA 2025 Abstract researchers explored whether or not a pharmacist could serve as the lead of a diabetes coaching program, aiming to reduce medical expenditures and A1C levels for at-risk patients.

Patients receiving support from pharmacist coaches experienced a remarkable average A1C decrease of 1.6% over 12 months compared with only a 0.5% decrease in the control group. #diabetes #ADASciSessions

Read More: bit.ly/3FSqnWR

Glycemic Control Trumps Weight Loss for Type 2 Diabetes Prevention, with Arvid Sandforth, MD Sandforth emphasized the important of achieving prediabetes remission for preventing T2D as seen in his new research.

"It's not overweight or obesity per se. It's the wrong lipids at the wrong place,” Sandforth said. “Type 2 #diabetes, that's hyperglycemia, [is] the thing we're trying to prevent. So why not look at glycemia when it comes to prevention?"

www.hcplive.com/view...

#ADASciSessions

👉 What was your favorite sketch? Drop it in the comments!
#ADASciSessions @amdiabetesassn.bsky.social #diabetesresearch #sketchnotes #precisionmedicine #endocrinology #medicalillustration

Smart solutions in pediatric diabetes at #ADASciSessions:
🧠 Atypical forms matter – Dr. Tosur
🏃‍♀️ Physical activity support – Dr. Zaharieva
📱 Shared med visits to boost tech, tailored by culture – Dr. Wong
#PedsEndo #DiabetesTech

How it started and how it ended. Until next year #ADASciSessions !

Lots of interesting technology for #diabetes #ADASciSessions these are just some examples.

🎉 Celebrating #NIDDK’s 75th anniversary at #ADASciSessions!
Legacy of DCCT/EDIC, TrialNet, innovative tissue networks, & the power of federal funding—all pushing diabetes research forward. Huge respect to the trailblazers in this space!

A bar chart showing the percentage of patients achieving the primary composite outcome in semaglutide versus placebo groups.

At #ADASciSessions, Shah et al. report results of an RCT of semaglutide in patients with T1DM and obesity. Read the full report in NEJM Evidence: eviden.cc/43YIrGt

#MedSky

Presented at the #ADASciSessions:

The MariTide phase 2 trial of once-monthly maridebart cafraglutide, a peptide–antibody conjugate, showed substantial weight reduction in participants with obesity with or without type 2 diabetes. Full trial results: nej.md/3ZHxLeb

How is #AI reshaping our understanding of #diabetes?
Join Dr. Wei Wang at #ADASciSessions for:
🧠 Diabetes Disease Modeling in the Era of AI
📅 June 23 | ⏰ 3:15–4:15 AM PT
📍 Room W192 A–C
Session: Decoding Diabetes—AI-Driven Advances in Genetic Research
dknet.org/about/blog/2...

📍 Don’t miss your chance to stop by the #NIDDK #DataScience Corner at #ADA2025 #ADASciSessions!
Explore tools, datasets & connect with experts from:
#dkNET, NIDDK-CR, PanKbase, HIRN, CMDKP, IIDP, MMPC, TEDDY, RADIANT, TrialNet & CODA — all in one place!
🔗 dknet.org/data-science...

Discover the groundbreaking potential of Dorzagliatin, an innovative diabetes treatment developed by Hua Medicine, that could revolutionize the management of type 2 diabetes. @amdiabetesassn.bsky.social‬ #ADASciSessions youtu.be/WF09pQPgr6M

Bringing together lived experience experts, researchers, healthcare professionals & more - Diabetes Australia is committed to eliminating the impact of diabetes by leading a transformative, community-driven approach to research. @amdiabetesassn.bsky.social‬ #ADASciSessions youtu.be/2m2K2Qqd5Rc

Discover Endo Axiom, an Australian biotechnology company developing the next generation of precision nanomedicines to treat diabetes & autoimmune diseases. ‪@amdiabetesassn.bsky.social‬ #ADASciSessions youtu.be/xUd_KWr42ww

Figure. Key Pathophysiologic Defects in Type 2 Diabetes and Primary Sites of Action of Glucose-Lowering Medications

Type 2 diabetes affects up to 14% of the global population. This Review discusses the diagnosis, treatment, and prognosis of adults with type 2 diabetes.

#ADASciSessions @amdiabetesassn.bsky.social

https://ja.ma/3HK0lFM

🎉This weekend, Vindico brought the Amylin Adventure to #ADASciSessions!

Over 500 health care professionals joined us to explore amylin’s role as a multifunctional hormone!

Thank you to the @amdiabetesassn.bsky.social, our faculty, Vindico team and supporter (Novo Nordisk, Inc.)!

Global diabetes care is rapidly evolving, see how ongoing research at Hua Medicine reflects a commitment to addressing the rising burden of diabetes through science-driven, patient-focused solutions. @amdiabetesassn.bsky.social‬ #ADASciSessions youtu.be/RuS4IVNhZ5c

🚨 Last chance! Swing by Booth #947 at #ADA2025 #ADASciSessions to meet the #dkNET team!
✅ Live demos
✅ Resource Reports
✅ FAIR data resources
✅ Data Science resources
✅ AI/ML platform
Everything you need to boost your #diabetes research
Stop by before the exhibits close!
dknet.org/about/blog/2...

Final day at #ADA2025 #ADASciSessions! Stop by the #NIDDK #DataScience Corner to connect with teams offering tools, datasets & resources: #dkNET, NIDDK-CR, PanKbase, HIRN, CMDKP, IIDP, MMPC, TEDDY, RADIANT, TrialNet & CODA — all in one space! 🔗 dknet.org/data-science...

When it comes to weight loss in pregnancy with obesity – is it a risky gamble or a beneficial bet? That’s today’s Debate in Diabetes! Tune in as we dive into both viewpoints with Dr. Kimberly Vesco & Dr. Claire Meek. ‪@amdiabetesassn.bsky.social‬ #ADASciSessions youtu.be/HgqKgAuDdj0

After 18 hours in transit, more plane delays in travel, rainstorms and lack of sleep, I’m finally home from #ADASciSessions. Met lots of people, new and old and stimulated some new ideas in the fight to end #diabetes! Grateful for @diabresearch-dzd.bsky.social support of our presented project!

Continuing with a focus on epidemiology, Tune in as ADA TV talks with Dr. Juliana Chan, the 2025 Kelly West Award winner for Outstanding Achievement in Epidemiology. ‪@amdiabetesassn.bsky.social‬ #ADASciSessions youtu.be/7gs8CEVqIFY

A first at the #ADASciSessions this year – we hear from the 2025 Distinguished International Service award recipient, Dr. Venkat Narayan! ‪@amdiabetesassn.bsky.social‬ youtu.be/AMjXY0nQhTg

Curious about this year's #ADASciSessions highlights? ADA TV sits down in the ADA Hub in the Sip & Chat booth with Dr. Alice Cheng to take a look back at what a week it’s been! ‪@amdiabetesassn.bsky.social‬ youtu.be/rq93XlujRCg